Page last updated: 2024-12-05

glyoxal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7860
CHEMBL ID1606435
CHEBI ID34779
MeSH IDM0009511

Synonyms (75)

Synonym
BIDD:ER0284
ethane-1,2-dial
glyoxal aldehyde
CHEBI:34779 ,
oxal
glyoxal ,
glyoxal, biformyl, oxalaldehyde
oxaldehyde
ethanedial
107-22-2
NCGC00091228-01
1,2-ethanedione
oxalaldehyde
biformal
aerotex glyoxal 40
biformyl
diformyl
hsdb 497
glyoxal, 40%
glyoxal, 29.2%
brn 1732463
diformal
ccris 952
ai3-24108
glyoxylaldehyde
einecs 203-474-9
nsc-262684
nsc262684
40094-65-3
ethanedial, trimer
ethanedione
G0152
AKOS000119169
ec 203-474-9
unii-50np6jj975
4-01-00-03625 (beilstein handbook reference)
50np6jj975 ,
tox21_202517
NCGC00260066-01
BBL011519
cas-107-22-2
dtxsid5025364 ,
tox21_111105
dtxcid505364
glyoxal, 40% w/w aq. soln.
STL146635
FT-0626792
ethane-1,2-dione
glyoxal [mi]
glyoxal [mart.]
glyoxal [who-dd]
glyoxal [hsdb]
glyoxal [inci]
ethane dial
(oxo)acetaldehyde
oxalic acid dihydride
CHEMBL1606435
protectol gl 40
(cho)2
ethandial
odix
mfcd00006957
J-001740
F2191-0152
hydroxymethylene ketone
Q413465
STR01281
glyoxal (ethanedial)
EN300-19156
glyoxal, 40% solution
glyoxal (mart.)
daicel gy 60
gohsezal p
glyfix cs 50
permafresh 114

Research Excerpts

Overview

Glyoxal (GO) is a reactive intermediate which has the ability to modify proteins and generate AGEs at a faster rate. Glyoxal is an important precursor to secondary organic aerosol (SOA) formed through aqueous chemistry in clouds, fogs, and wet aerosols.

ExcerptReferenceRelevance
"Glyoxalase-1 (GLO-1) acts as a part of the anti-glycation defense system by carrying out detoxification of GO and MGO."( The Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders.
Akhter, A; Kausar, MA; Saeed, M; Siddiqui, AJ; Singh, R, 2020
)
1.66
"Glyoxal (GO) is a reactive intermediate which has the ability to modify proteins and generate AGEs at a faster rate."( Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis.
Das, S; Roy, AS; Sarmah, S, 2020
)
1.51
"Glyoxal is a physiological metabolite formed by lipid peroxidation, ascorbate autoxidation, oxidative degradation of glucose, and degradation of glycated proteins. "( Glyoxal toxicity in isolated rat liver mitochondria.
Goudarzi, M; Kalantari, H; Rezaei, M, 2018
)
3.37
"Glyoxal, which is a dialdehyde obtained from several natural resources, was used as substitute for formaldehyde."( Production of oil palm (Elaeis guineensis) fronds lignin-derived non-toxic aldehyde for eco-friendly wood adhesive.
Brosse, N; Gambier, F; Hazwan Hussin, M; Latif, NHA; Rozuli, NA; Samad, NA; Yusoff, SB, 2018
)
1.2
"Glyoxal is an oxoaldehyde generated from the degradation of glucose-protein conjugates and from lipid peroxidation in foods and in vivo, and it is also present in the environment (e.g., cigarette smoke). "( Correlation between Glyoxal-Induced DNA Cross-Links and Hemoglobin Modifications in Human Blood Measured by Mass Spectrometry.
Chen, HC; Li, YJ; Liu, CT, 2019
)
2.28
"Glyoxal is an important precursor to secondary organic aerosol (SOA) formed through aqueous chemistry in clouds, fogs, and wet aerosols, yet the gas-particle partitioning of the resulting mixture is not well understood. "( Ammonium addition (and aerosol pH) has a dramatic impact on the volatility and yield of glyoxal secondary organic aerosol.
Häkkinen, SA; Lim, YB; McNeill, VF; Ortiz-Montalvo, DL; Schwier, AN; Turpin, BJ, 2014
)
2.07
"Glyoxal is a physiological metabolite produced during formation of AGEs and has also been shown to derive from photodegraded bisretinoid fluorophores in aging retinal pigment epithelial (RPE) cells."( Stress responses of human retinal pigment epithelial cells to glyoxal.
Frenzel, A; Funk, RH; Goetze, D; Knels, L; Morawietz, H; Roehlecke, C; Valtink, M, 2016
)
1.4
"Glyoxal (gx) is an alpha-dicarbonyl species derived endogenously from the metabolism of carbohydrates or nitrosamines and from oxidation of lipids and nucleic acids. "( Analysis of glyoxal-induced DNA cross-links by capillary liquid chromatography nanospray ionization tandem mass spectrometry.
Chen, HJ; Chen, YC, 2009
)
2.17
"Glyoxal, HC(O)CHO, is an important trace component of the Earth's atmosphere, formed in biomass burning and in the photooxidation of volatile organic compounds (VOCs) like isoprene and aromatic hydrocarbons. "( Hydroxyl radical regeneration in the photochemical oxidation of glyoxal: kinetics and mechanism of the HC(O)CO + O(2) reaction.
da Silva, G, 2010
)
2.04
"Glyoxal is a highly reactive glycating agent involved in the formation of AGEs and is known to induce apoptosis, as revealed by the upregulation of caspase-3 and fractin (caspase-3 being a key enzyme activated during the late stage of apoptosis and fractin being a caspase-cleaved actin fragment)."( Collagen type I prevents glyoxal-induced apoptosis in osteoblastic cells cultured on titanium alloy.
Bierbaum, S; Funk, RH; Ma, C; Tippelt, S; Witt, M, 2004
)
1.35
"Glyoxal is a widely dispersed environmental mutagen that reacts with DNA and deoxyguanosine to give primarily the 1,N(2)-guanine adduct, i.e., 3-(2'-deoxy-beta-d-erythro-pentofuranosyl)-5,6,7-trihydro-6,7-dihydroxyimidazo[1,2-a]purin-9-one. "( Coupling products of nucleosides with the glyoxal adduct of deoxyguanosine.
Brock, AK; Harris, TM; Kozekov, ID; Rizzo, CJ, 2004
)
2.03
"Glyoxal is a reactive alpha-oxoaldehyde that is a physiological metabolite formed by lipid peroxidation, ascorbate autoxidation, oxidative degradation of glucose and degradation of glycated proteins. "( The cytotoxic mechanism of glyoxal involves oxidative stress.
O'Brien, PJ; Shangari, N, 2004
)
2.06
"Glyoxal (ethanedial) is an increasingly used industrial chemical that has been found to be mutagenic in bacteria and mammalian cells. "( Reaction of glyoxal with 2'-deoxyguanosine, 2'-deoxyadenosine, 2'-deoxycytidine, cytidine, thymidine, and calf thymus DNA: identification of DNA adducts.
Backman, J; Ellingsen, DG; Greibrokk, T; Kronberg, L; Lundanes, E; Molander, P; Olsen, R; Sjöholm, R; Thomassen, Y; Thorud, S; Øvrebø, S, 2005
)
2.15
"Glyoxal is a dialdehyde that is used as a disinfectant in health care and dentistry work. "( Occupational contact allergy to glyoxal.
Aalto-Korte, K; Huttunen, M; Jolanki, R; Mäkelä, EA; Suuronen, K, 2005
)
2.05
"Glyoxal is a significant atmospheric aldehyde formed from both anthropogenic aromatic compounds and biogenic isoprene emissions. "( Secondary organic aerosol formation by glyoxal hydration and oligomer formation: humidity effects and equilibrium shifts during analysis.
Bailey, EL; De Haan, DO; Hastings, WP; Koehler, CA, 2005
)
2.04
"Glyoxal is an interesting endogenous alpha-oxoaldehyde as it originates from pathways that have been linked to various pathologies, including lipid peroxidation, DNA oxidation and glucose autoxidation. "( Glyoxal markedly compromises hepatocyte resistance to hydrogen peroxide.
Chan, TS; O'Brien, PJ; Popovic, M; Shangari, N, 2006
)
3.22
"Glyoxal is an endogenous compound, the levels of which are increased in various pathologies associated with hyperglycaemia and other related disorders. "( Inactivation and modification of superoxide dismutase by glyoxal: prevention by antibodies.
Jabeen, R; Mohammad, A; Petersen, J; Saleemuddin, M, 2007
)
2.03
"Glyoxal is a major product of DNA oxidation in which Fenton-type oxygen free radical-forming systems are involved. "( Glyoxal, a major product of DNA oxidation, induces mutations at G:C sites on a shuttle vector plasmid replicated in mammalian cells.
Kaji, H; Kamiya, H; Kasai, H; Murata-Kamiya, N, 1997
)
3.18
"Glyoxal is a highly reactive glycating agent involved in the formation of advanced glycation end products (AGEs) and known to induce apoptosis. "( Resistance of L132 lung cell clusters to glyoxal-induced apoptosis.
Fehrenbach, H; Funk, RH; Kasper, M; Kuhnt, AK; Roehlecke, C; Werner, C, 2000
)
2.02
"Glyoxal is a key compound involved in glyoxal oxidase (GLOX)-dependent production of glyoxylate, oxalate and H2O2 by lignin-degrading basidiomycetes. "( Production and chemiluminescent free radical reactions of glyoxal in lipid peroxidation of linoleic acid by the ligninolytic enzyme, manganese peroxidase.
Honda, Y; Kuwahara, M; Okada, H; Shirai, N; Watanabe, T, 2001
)
2

Effects

Glyoxal-modified LDL has neo-antigenic determinants that cause the generation of circulating antibodies in diabetes and coronary artery disease. Glyoxal has been linked to oxidative stress and can cause a number of cellular damages.

ExcerptReferenceRelevance
"Glyoxal-modified LDL has neo-antigenic determinants that cause the generation of circulating antibodies in diabetes and coronary artery disease. "( Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease.
Abidi, M; Ali, A; Habib, S; Mir, AR; Rizwee, MM; Uddin, M, 2021
)
2.39
"Glyoxal has been linked to oxidative stress and can cause a number of cellular damages, including covalent modification of amino and thiol groups of proteins to form advanced glycation end products."( Glyoxal toxicity in isolated rat liver mitochondria.
Goudarzi, M; Kalantari, H; Rezaei, M, 2018
)
2.64
"The glyoxalase system has been studied since 1913. "( Glyoxalase in ageing.
Rabbani, N; Thornalley, PJ; Xue, M, 2011
)
2.37
"Glyoxal has been identified as a product in the fragmentation of reduced 2-nitroimidazole radiosensitizers. "( Reductive fragmentation of 2-nitroimidazoles: amines and aldehydes.
Liu, SF; Raleigh, JA, 1984
)
1.71
"Glyoxalase I (GLO) has 3 common phenotypes: GLO 1, GLO 2-1, and GLO 2."( Polymorphism of red cell glyoxalase I (EI: 4.4.1.5); a new genetic marker in man. Investigation of 169 mother-child combinations.
Bissbort, S; Gussmann, S; Kömpf, J; Ritter, H, 1975
)
1.28

Actions

ExcerptReferenceRelevance
"Glyoxal promotes a change in fibroblast behavior in favor of lipogenic activity that could be involved in delaying wound healing."( Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts.
Bonod, C; Bouschbacher, M; Clément, S; Ferraro, S; Guillon, C; Sigaudo-Roussel, D, 2021
)
2.43

Treatment

Glyoxal treatment significantly increased the incidence of adenocarcinomas in the pylorus of the glandular stomach of rats pretreated with MNNG and sodium chloride. Treatment induced carboxymethyl-lysin accumulation and delayed wound closure in the skin mimicking diabetic ulcers.

ExcerptReferenceRelevance
"Glyoxal treatment induced carboxymethyl-lysin accumulation and delayed wound closure in the skin mimicking diabetic ulcers."( In vitro glycation of a tissue-engineered wound healing model to mimic diabetic ulcers.
Bellenfant, S; Berthod, F; Cadau, S; De Serres-Bérard, T; Lemarchand, M; Thouin, K, 2023
)
1.63
"Glyoxal-treated hemoglobin exhibits decreased absorbance around 280 nm, decreased fluorescence and reduced surface hydrophobicity compared to normal hemoglobin. "( Effect of Glyoxal Modification on a Critical Arginine Residue (Arg-31α) of Hemoglobin: Physiological Implications of Advanced Glycated end Product an
Banerjee, S, 2020
)
2.4
"Glyoxal-treated Mb exhibited increased absorbance around the Soret region, decreased α-helicity and thermal stability compared to control Mb."( Formation of Pentosidine Cross-Linking in Myoglobin by Glyoxal: Detection of Fluorescent Advanced Glycation End Product.
Banerjee, S, 2017
)
1.42
"Glyoxal treatment that did not affect cell viability but inhibited cell proliferation in a dose-dependent manner that led to accumulation of CML-modified histones."( Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment.
Cervantes-Laurean, D; Jacobson, EL; Jacobson, MK; Roberts, MJ, 2005
)
1.26
"Glyoxal treatment significantly increased the incidence of adenocarcinomas in the pylorus of the glandular stomach of rats pretreated with MNNG and sodium chloride."( Effects of glyoxal and methylglyoxal administration on gastric carcinogenesis in Wistar rats after initiation with N-methyl-N'-nitro-N-nitrosoguanidine.
Furukawa, F; Hayashi, Y; Imaida, K; Okamiya, H; Sato, H; Takahashi, M; Toyoda, K, 1989
)
1.39

Toxicity

ExcerptReferenceRelevance
" In this study, the changes in the cellular and extracellular concentrations of these alpha-oxoaldehydes were investigated in murine P388D1 macrophages during necrotic cell death induced by median toxic concentrations of hydrogen peroxide and 1-chloro-2,4-dinitrobenzene (CDNB)."( Accumulation of alpha-oxoaldehydes during oxidative stress: a role in cytotoxicity.
Abordo, EA; Minhas, HS; Thornalley, PJ, 1999
)
0.3
" Thus fructose was seventy-fold more toxic if hepatocytes were exposed to non-toxic levels of hydrogen peroxide (H(2)O(2)) released by inflammatory cells."( Hepatocyte inflammation model for cytotoxicity research: fructose or glycolaldehyde as a source of endogenous toxins.
Bruce, J; Bruce, WR; Dong, Q; Feng, CY; Mehta, R; O'Brien, PJ; Wong, S, 2009
)
0.35
" Administration of this drug, often in a chronic manner, is associated with several adverse drug reactions in humans, including life-threatening hepatotoxicity."( Mechanisms of methimazole cytotoxicity in isolated rat hepatocytes.
Babaei, H; Eghbal, M; Heidari, R, 2013
)
0.39
"Glyoxal (GO) and methylglyoxal (MGO) cause protein and nucleic acid carbonylation and oxidative stress by forming reactive oxygen and carbonyl species which have been associated with toxic effects that may contribute to cardiovascular disease, complications associated with diabetes mellitus, Alzheimer's and Parkinson's disease."( Protective effects of ferulic acid and related polyphenols against glyoxal- or methylglyoxal-induced cytotoxicity and oxidative stress in isolated rat hepatocytes.
Lip, H; Maruf, AA; O'Brien, PJ; Wong, H, 2015
)
2.1

Compound-Compound Interactions

ExcerptReferenceRelevance
" In this study, their levels were measured using a sample preparation procedure based on salting-out assisted liquid-liquid extraction (SALLE) and dispersive liquid-liquid microextraction (DLLME) combined with gas chromatography-mass spectrometry (GC-MS)."( Glyoxal and methylglyoxal as urinary markers of diabetes. Determination using a dispersive liquid-liquid microextraction procedure combined with gas chromatography-mass spectrometry.
Campillo, N; Fernández-García, AJ; Hernández-Córdoba, M; Motas, M; Pastor-Belda, M; Pérez-Cárceles, MD; Viñas, P, 2017
)
1.9

Bioavailability

ExcerptReferenceRelevance
" The data also indicate that digestion can reduce the bioavailability of the toxic α-dicarbonyl compounds ingested with food."( Effect of in vitro digestion on free α-dicarbonyl compounds in balsamic vinegars.
Gazzani, G; Marrubini, G; Mascherpa, D; Papetti, A, 2013
)
0.39
" These findings suggest that α-DC bioavailability could actually depend not on food content but rather on reactions occurring during digestion."( Free α-dicarbonyl compounds in coffee, barley coffee and soy sauce and effects of in vitro digestion.
Gazzani, G; Mascherpa, D; Papetti, A, 2014
)
0.4
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" 2"-O-GIV exhibited a dose-response effect but alpha-tocopherol did not."( Inhibitory effect of 2"-O-glycosyl isovitexin and alpha-tocopherol on genotoxic glyoxal formation in a lipid peroxidation system.
Hagiwara, H; Hagiwara, Y; Nishiyama, T; Shibamoto, T, 1994
)
0.52
" This observation suggests a strategy of individualized dosing adapted to hematotoxicity."( Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M, 2004
)
0.32
" Primary therapies were divided into four groups: radiotherapy alone, moderately dosed COPP/ABVD-like chemotherapies for intermediate and advanced stages and BEACOPP escalated."( Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M, 2011
)
0.37
"Response surface methodology (RSM) was utilized to investigate the dose-response relationships of a phenolic mixture (catechin, genistein and daidzein) as a pre-thermal processing technique to reduce reactive carbonyl species (RCSs; glyoxal, methylglyoxal and 3-deoxyglucosone) in ultra-high temperature (UHT) bovine milk."( Response surface methodology as optimization strategy for reduction of reactive carbonyl species in foods by means of phenolic chemistry.
Kokkinidou, S; Peterson, DG, 2013
)
0.57
" Moreover, the high dosage and pH stabilization of additional GO probably promoted the ARP degradation and deoxyosones retro-aldol cleavage, resulting in methylpyrazine rather than furanoids formation."( Characteristic flavor formation of thermally processed N-(1-deoxy-α-d-ribulos-1-yl)-glycine: Decisive role of additional amino acids and promotional effect of glyoxal.
Cui, H; Hayat, K; Ho, CT; Wu, X; Yu, J; Zhan, H; Zhang, X, 2022
)
0.92
" The priority of the Cys reaction with different α-dicarbonyls and its dependence on the Cys dosage were investigated."( Formation Priority of Pyrazines and 2-Acetylthiazole Dependent on the Added Cysteine and Fragments of Deoxyosones during the Thermal Process of the Glycine-Ribose Amadori Compound.
Hayat, K; Ho, CT; Liu, M; Xu, H; Yu, J; Zhang, X; Zhou, T, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
pesticideStrictly, a substance intended to kill pests. In common usage, any substance used for controlling, preventing, or destroying animal, microbiological or plant pests.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
plant growth regulatorA chemical, natural or artificial, that can affect the rate of growth of a plant.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dialdehydeAny aldehyde with two aldehyde groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency84.12670.047349.480674.9780AID651758
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency25.11890.011212.4002100.0000AID1030
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency49.94370.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.08540.000229.305416,493.5996AID743079
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency13.33320.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency74.97800.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1337095Inhibition of human MPO2017ACS medicinal chemistry letters, Feb-09, Volume: 8, Issue:2
From Dynamic Combinatorial Chemistry to
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,084)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990277 (25.55)18.7374
1990's91 (8.39)18.2507
2000's234 (21.59)29.6817
2010's315 (29.06)24.3611
2020's167 (15.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 72.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index72.98 (24.57)
Research Supply Index7.03 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index128.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (72.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials7 (0.63%)5.53%
Reviews39 (3.49%)6.00%
Case Studies5 (0.45%)4.05%
Observational2 (0.18%)0.25%
Other1,066 (95.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]